REFERENCES
- http://www.who.int/reproductive-health/publications/maternal_mortality_2000/mme.pdf, Maternal mortality in 2000. Estimates developed by WHO, UNICEF and UNFPA
- http://www.sante.gov.ma/indicateurdesante/INDICATEURSDESANTE.pdf, Rayaume du Maroc. Ministère de la Santé. Indicateurs de santé (2003).
- Miguil M. Réanimation des urgencies obstétricales. Imprimerie le Colombier, Casablanca 2005
- Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ 1994; 309(26)1395–1400
- Jamelle RN. Eclampsia—a taxing situation in third world. International J Gynecol Obstet 1997; 58: 311–312
- Cisse CT, Ewagnignon P. Eclampsia en milieu Africain. Sem Hop Paris 1997; 73: 33–34
- Miguil M, Salmi S, Mouhaoui M, El Youssoufi S. Aspects épidémiologiques et pronostiques de l'éclampsie. Cah Anesthesiol 2003; 51(3)177–180
- Conde-agudelo A, Kafury-Goeta AC. Case-control study of risk factors for complicated eclampsia. Obstet Gynecol 1997; 90: 172–175
- Sibai BM. Eclampsia: maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990; 163: 1049–1055
- Bouaggad A, Barrou L, Benslama A, et al. Complications cérébrales de l'éclampsie. J Gynecol Obstet Biol Reprod 1994; 23: 819–824
- Mjahed K, Hamammouchi B, Hammoudi D, et al. Analyse critique des troubles de l'hémostase. J Gynecol Obstet Biol Reprod 1998; 27(6)607–610
- Bhagwanjee S, Paruk F, Moodley J, et al. Intensive care unit morbidity from eclampsia: an evaluation of the acute physiology and chronic health evaluation II score and the glascow coma scale score. Crit care Med 2000; 28(1)120–124
- Vigil-de Gracia P, Garcia-Caceres E. Thrombocytopenia, hypertension and seizures in eclampsia. Internat J Gynecol Obstet 1998; 61: 15–20
- Kam PCA, Thompson SA, Liew ACS. Thrombocytopenia in parturient. Anaesthesia 2004; 59: 255–264
- Martin JN, Jr, Thigpen BD, Moore RC, et al. Stroke and severe eclampsia: A paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105: 246–254
- Cunnigham FG. Severe preeclampsia and eclampsia: systolic hypertension is also important. Obstet Gynecol 2005; 105: 237–238
- Mattar F, Sibai BM. Eclampsia. Risk factors for maternal morbidity. Am J Obstet Gynecol 2000; 182(2)307–312
- Katz VL, Farmer R, Kuller JA. Preeclampsia into eclampsia: toward a new paradigm. Am J Obstet Gynecol 2000; 182(6)1389–1396
- Isler CM, Barrilleaux PS, Rinehart BK, et al. Post-partum seizure prophylaxis: Using maternal clinical parameters to guide therapy. Obstet Gynecol 2003; 101: 66–69
- Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, beneseizures from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359: 1877–1890
- Crowther C. Magnesium sulphate versus diazepam in the management of eclampsia: a randomized controlled trial. Br J Obstet Gynecol 1990; 97: 110–117
- Lucas MJ, Leveno KJ, Cunningham FG. A comparaison of magnesium sulfate with phenytoine for the prevention of eclampsia. N Eng J Med 1995; 333: 201–205
- Miguil M, Chlihi A, Mjahed K, et al. Nécrose hépatique mortelle au cours d'un traitement par le valproate de sodium. Cahiers d'anesthésiologie 1995; 43(3)325–325
- Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstetrics & Gynecology 2004; 103(5)981–991